INS and Hyperglycemia: Administration of mATG in combination with a subcutaneously implanted insulin pellet to spontaneously diabetic NOD mice resulted in durable remission from overt hyperglycemia in 40% of treated mice (4 out of 10), confirming our previous findings [3].